SIRT1-modified human umbilical cord mesenchymal stem cells ameliorate experimental peritoneal fibrosis by inhibiting the TGF-β/Smad3 pathway

INTRODUCTION: Peritoneal fibrosis is a serious complication of long-term peritoneal dialysis (PD). Combination therapies are emerging as a promising treatment for tissue damage. Here, we investigated the therapeutic potential of SIRT1-modified human umbilical cord mesenchymal stem cells (hUCMSCs) fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yanhong, Wang, Liuwei, Gou, Rong, Wang, Yulin, Shi, Xiujie, Pang, Xinxin, Tang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436980/
https://www.ncbi.nlm.nih.gov/pubmed/32811535
http://dx.doi.org/10.1186/s13287-020-01878-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436980/
https://www.ncbi.nlm.nih.gov/pubmed/32811535
http://dx.doi.org/10.1186/s13287-020-01878-2

Ejemplares similares